DexCom held its 2026 Annual Meeting of Stockholders on May 27, 2026. A quorum was established with 336,525,352 shares present or represented by proxy out of 385,872,977 outstanding shares. All twelve director nominees were elected to serve until the 2027 annual meeting. Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026. Stockholders approved the advisory vote on named executive officer compensation.